TRILOGY MEDWASTE, INC. – Trademark Portfolio
Entity Type: 03
TRILOGY MEDWASTE, INC. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 40 (Treatment & Processing) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 7 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include CORE PLUS, PHARMADROP, CORE ESSENTIALS, TRILOGY MEDWASTE, and BIRDS EYE TECHNOLOGIES. The owner is based in Houston, TX.
Suite 200
8554 Katy Freeway
Houston, TX 77024
Showing of trademarks Trademarks
Trademark Classifications
TRILOGY MEDWASTE, INC.'s trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does TRILOGY MEDWASTE, INC. have?
TRILOGY MEDWASTE, INC. has 9 U.S. trademarks filed with the USPTO. Of these, 7 registered, 2 abandoned.
What trademark classes does TRILOGY MEDWASTE, INC. file in?
TRILOGY MEDWASTE, INC. files trademarks across 7 Nice Classification classes. The most active classes are Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 39 (Transportation & Storage), Class 35 (Advertising & Business), Class 20 (Furniture). Class 40 covers treatment of materials.
What are TRILOGY MEDWASTE, INC.'s most well-known trademarks?
TRILOGY MEDWASTE, INC.'s registered trademark portfolio includes well-known marks such as CORE PLUS, PHARMADROP, CORE ESSENTIALS, TRILOGY MEDWASTE, and BIRDS EYE TECHNOLOGIES. These are among 7 currently registered trademarks in the portfolio.
What is TRILOGY MEDWASTE, INC.'s trademark registration success rate?
TRILOGY MEDWASTE, INC. has a 78% trademark registration rate, with 7 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.